BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹75 Cr | ₹71 Cr | ₹15 Cr | ₹68 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of BLISS GVS PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹75 Cr |
| Mar2024 | ₹71 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹97 Cr |
How is Consolidated Net Profit of BLISS GVS PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹75 Cr | 6.48 | |
| Mar2024 | ₹71 Cr | 371.14 | |
| Mar2023 | ₹15 Cr | -78.04 | |
| Mar2022 | ₹68 Cr | -29.58 | |
| Mar2021 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,032.0 Cr | 31.2% | 45.1% | 161.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,279.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,649.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 31.2% |
45.1% |
161.7% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses